Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CSL787 in Non-cystic Fibrosis Bronchiectasis
NCT07048262Phase 2Recruiting
- Sponsor
- CSL Limited
- Start
- Sep 2025
- Primary completion
- May 2029
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 2
01
Overview
A Phase 2 trial of CSL787 in Non-cystic fibrosis bronchiectasis (NCFB), sponsored by CSL Limited. Started Sep 2025; status: recruiting.
02
Drugs
CSL787
03
Conditions
Non-cystic fibrosis bronchiectasis (NCFB)
Beyond the preview
Go deeper on NCT07048262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07048262.